Supplementary figure S1 from Drug-Driven Synthetic Lethality: Bypassing Tumor Cell Genetics with a Combination of AsiDNA and PARP Inhibitors
Wael Jdey, Marie Dutreix(Centre National de la Recherche Scientifique), Inna Kuperstein(Inserm), Yves Pommier(National Cancer Institute), Flavien Devun(HiFiBiO Therapeutics (France)), Emmanuel Barillot(Inserm), Patricia Noguiez‐Hellin(Genopole (France)), Jian‐Sheng Sun(HiFiBiO Therapeutics (France)), Andreï Zinovyev(Inserm), Christophe Russo(Inserm), Sylvain Thierry(Université Paris-Sud), Muthana Al Abo(National Cancer Institute)
Cited by 0
Related Papers
Fibroblast Heterogeneity and Immunosuppressive Environment in Human Breast Cancer
|Cancer Cell|2018|1.7k
Creation and analysis of biochemical constraint-based models using the COBRA Toolbox v.3.0
|Nature Protocols|2019|1.4k
Neurotoxicity of Alzheimer's disease Aβ peptides is induced by small changes in the Aβ42 to Aβ40 ratio
|The EMBO Journal|2010|539
Human topoisomerases and their roles in genome stability and organization
|Nature Reviews Molecular Cell Biology|2022|446
The Virtual Metabolic Human database: integrating human and gut microbiome metabolism with nutrition and disease
|Nucleic Acids Research|2018|431